Loading…
Equillium, Inc. is projected to rise to $5.02 by 2027, a +91% move from its current price of $2.63. EQ is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean strong buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 5/28/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| May 29 | $2.46 | $2.63 | $2.81 | +0.06% |
| May 30 | $2.40 | $2.63 | $2.89 | +0.13% |
| May 31 | $2.35 | $2.64 | $2.96 | +0.19% |
| Jun 1 | $2.31 | $2.64 | $3.01 | +0.26% |
| Jun 2 | $2.27 | $2.64 | $3.06 | +0.32% |
| Jun 3 | $2.24 | $2.64 | $3.11 | +0.39% |
| Jun 4 | $2.21 | $2.64 | $3.15 | +0.45% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $2.21 | $2.64 | $3.15 | +0.45% |
| Week 2 | $2.07 | $2.65 | $3.41 | +0.91% |
| Week 3 | $1.96 | $2.67 | $3.62 | +1.37% |
| Week 4 | $1.88 | $2.68 | $3.82 | +1.83% |
| Week 5 | $1.81 | $2.69 | $4.00 | +2.29% |
| Week 6 | $1.75 | $2.70 | $4.17 | +2.75% |
| Week 7 | $1.70 | $2.71 | $4.34 | +3.22% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Equillium, Inc. is a clinical-stage biotechnology company that focuses on developing therapeutics to treat autoimmune and inflammatory disorders in the United States. Its EQ504 program is a novel AhR modulator in preclinical-stage for ulcerative colitis and lung inflammation diseases.
Equillium also develops EQ302, a bi-specific inhibitor of IL-15 and IL-21 formulated for oral delivery for the treatment of celiac diseases. The company was formerly known as Attenuate Biopharmaceuticals, Inc. and changed its name to Equillium, Inc.
in May 2017. Equillium, Inc. was incorporated in 2017 and is headquartered in La Jolla, California.
Equillium, Inc. (EQ) operates in the healthcare sector with a current price of $2.63 and a market cap of $166.29M. It ranks 3911 by market capitalization. The current price aligns with the year-ahead forecast that envisions a path from near-term neutrality to longer-term upside, reflected in a rising average price forecast across multiple years.
By 2050, the forecast projects a substantial lift in value with a wide potential range.
A major floor 57.8% below — a decisive break under it would weaken the trend.
The nearest floor, 32.7% below — buyers have tended to step in here.
Price is pressing into resistance (0.0% away) — a breakout level to watch.
A major ceiling 21.8% above — clearing it would confirm fresh momentum.
Key EQ support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of EQ market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $2.30 | Buy | $2.35 | Buy |
| MA 10 | $2.22 | Buy | $2.26 | Buy |
| MA 20 | $2.17 | Buy | $2.19 | Buy |
| MA 50 | $2.08 | Buy | $2.06 | Buy |
| MA 100 | $1.82 | Buy | $1.87 | Buy |
| MA 200 | $1.58 | Buy | $1.59 | Buy |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 63.23 | Neutral |
| Stoch RSI (14) | 75.96 | Neutral |
| CCI (20) | 209.08 | Buy |
| Williams %R (14) | 0.00 | Info |
| MACD (12,26,9) | 0.03 | Buy |
| ROC (12) | 24.64 | Buy |
| Bollinger %B (20,2) | 1.07 | Sell |
| Stochastic %K (14) | 100.00 | Sell |
| TRIX (15) | 0.30 | Buy |
| Awesome (5,34) | 0.18 | Buy |
| Ultimate (7,14,28) | 64.53 | Neutral |
| Momentum (10) | 0.36 | Buy |
| Aroon Osc (25) | 20.00 | Buy |
| Hull MA (9) | 2.45 | Buy |
| ADX (14) | 13.21 | Neutral |
| ATR (14) | 0.14 | Info |
The 30-day technical picture shows bullish sentiment overall, with RSI at 60 and moving averages above the 30-day level. The SMA50 is $2.08 and the SMA200 is $1.58, placing near-term price action above longer-term trend indicators. The stock trades within a 30-day range of $1.69 to $4.09, with near-term support at $1.77 and resistance at $2.63.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $1.06 | $2.63 | $4.50 | 0% | Neutral | |
| $3.61 | $5.02 | $7.55 | +91% | Bullish | |
| $4.67 | $6.88 | $11.00 | +162% | Bullish | |
| $4.79 | $7.43 | $12.46 | +183% | Bullish | |
| $4.91 | $7.99 | $13.93 | +204% | Bullish | |
| $5.30 | $9.01 | $16.25 | +243% | Bullish | |
| $5.06 | $8.96 | $16.66 | +241% | Bullish | |
| $6.09 | $11.24 | $21.46 | +327% | Bullish | |
| $7.92 | $15.20 | $29.76 | +478% | Bullish | |
| $9.27 | $18.49 | $37.03 | +603% | Bullish | |
| $10.49 | $23.31 | $51.27 | +786% | Bullish | |
| $31.00 | $68.88 | $158.43 | +25.2x | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| May 2026 | $1.06 | $2.63 | $3.17 | +0.00% |
| June 2026 | $2.41 | $2.89 | $3.59 | +9.89% |
| July 2026 | $2.29 | $2.79 | $3.56 | -3.47% |
| August 2026 | $2.26 | $2.79 | $3.63 | +0.05% |
| September 2026 | $2.44 | $3.05 | $4.02 | +9.12% |
| October 2026 | $2.46 | $3.10 | $4.15 | +1.80% |
| November 2026 | $2.36 | $3.01 | $4.08 | -2.85% |
| December 2026 | $2.56 | $3.29 | $4.50 | +9.12% |
Click any year to see its month-by-month EQ forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
By 2026, EQ could reach as high as $4.50, with a base case around $2.63 and support toward $1.06 — roughly 0% from $2.63. A consolidation phase looks the most probable path here.
Expect EQ to range from $3.61 to $7.55 through 2027. The $5.02 average target implies a +91% move from current prices. That is up +91% on the projected 2026 average. Momentum favours further upside here.
The EQ price prediction for 2028 points to an average of $6.88 (low $4.67, high $11.00) — a potential gain of +162% on today's $2.63. Buyers look set to stay in control over this stretch.
In 2029, EQ is projected to trade between $4.79 and $12.46, averaging $7.43 — a potential gain of +183% from today's $2.63. That is up +8% on the projected 2028 average. Momentum favours further upside here.
Equillium, Inc.'s 2030 outlook centres on $7.99, within a $4.91 to $13.93 range. That is up +7% on the projected 2029 average. That marks a +204% change versus current levels. Buyers look set to stay in control over this stretch.
By 2031, EQ could reach as high as $16.25, with a base case around $9.01 and support toward $5.30 — roughly +243% from $2.63. Momentum favours further upside here.
Expect EQ to range from $5.06 to $16.66 through 2032. The $8.96 average target implies a +241% move from current prices. That is -1% versus the projected 2031 average. Buyers look set to stay in control over this stretch.
The EQ price prediction for 2033 points to an average of $11.24 (low $6.09, high $21.46) — a potential gain of +327% on today's $2.63. Momentum favours further upside here.
In 2034, EQ is projected to trade between $7.92 and $29.76, averaging $15.20 — a potential gain of +478% from today's $2.63. That is up +35% on the projected 2033 average. Buyers look set to stay in control over this stretch.
Equillium, Inc.'s 2035 outlook centres on $18.49, within a $9.27 to $37.03 range. That is up +22% on the projected 2034 average. That marks a +603% change versus current levels. Momentum favours further upside here.
By 2040, EQ could reach as high as $51.27, with a base case around $23.31 and support toward $10.49 — roughly +786% from $2.63. Buyers look set to stay in control over this stretch.
Expect EQ to range from $31.00 to $158.43 through 2050. The $68.88 average target implies a +25.2x move from current prices. That is up +195% on the projected 2040 average. Momentum favours further upside here.
Investing $1,000 in EQ today (≈ 380.228137 EQ) could be worth
$26,190.78
+$25,190.78 (+2519%) by 2050 · US Dollar
Based on the average projected EQ price of $68.88 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in EQwould be worth at today's price.
$1,000 invested in EQ on May 27, 2025 (≈ 2,499.999963 EQ) would be worth
$6,575
+$5,575 (+557.5%) today · 6.57× · US Dollar
Based on a EQ entry price of $0.4 vs. today's $2.63.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $2.06 | $1,276.7 | +27.7% |
| 1 month ago | $2.04 | $1,289.22 | +28.9% |
| 3 months ago | $1.74 | $1,511.49 | +51.1% |
| 6 months ago | $0.9 | $2,922.22 | +192.2% |
| 1 year ago | $0.4 | $6,575 | +557.5% |
| All time (5.0y) ago | $6.6 | $398.48 | -60.2% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our EQ forecast.
Our base-case forecast reaches $5.30 around 2028.
Implied market cap at $5.30: $335.1M
The multi-year forecast begins with 2026, where min $1.06, avg $2.63, max $4.50 and ROI 0% reflect a neutral stance. In 2027 the outlook turns bullish, with avg $5.02 and ROI 90.9%. The path continues higher through 2028 ($6.88, ROI 161.7%) and 2029 ($7.43, ROI 182.6%), reaching an average of $7.99 in 2030 with ROI 203.7%.
Subsequent years stay bullish, with 2031 avg $9.01 (ROI 242.6%), 2032 avg $8.96 (ROI 240.8%), and 2033 avg $11.24 (ROI 327.3%), followed by 2034 avg $15.20 (ROI 478%), and 2035 avg $18.49 (ROI 603%). The trajectory extends to 2040 with avg $23.31 (ROI 786.3%) and by 2050 to avg $68.88 (ROI 2519.1%). The maximum forecast price in 2050 is $158.43.
These figures imply substantial upside potential with bullish sentiment in most years, though the outlook remains uncertain and is not a guarantee.
Tap a question to reveal the answer.
In 2030 the forecast shows an average price of $7.99, with a minimum of $4.91 and a maximum of $13.93, and an estimated ROI of 203.7%.
The forecast shows a bullish sentiment from 2027 onward with rising averages and high ROIs (e.g., 203.7% in 2030, 786.3% by 2040, and 2519.1% by 2050), though 2026 is neutral. These are estimates, not guarantees.
The 2050 forecast projects an average price of $68.88, a max of $158.43, and an ROI of 2519.1%.
The current price is $2.63 and the market cap is $166.29M.
Key upside appears in 2030 (avg $7.99, ROI 203.7%), 2040 (avg $23.31, ROI 786.3%), and 2050 (avg $68.88, ROI 2519.1%), with bullish sentiment in most years beyond 2026.
Equillium, Inc. Community Discussion
0Share your Equillium, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.